These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 29170979)

  • 1. The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months.
    Beukelman T; Kimura Y; Ilowite NT; Mieszkalski K; Natter MD; Burrell G; Best B; Jones J; Schanberg LE;
    Pediatr Rheumatol Online J; 2017 Apr; 15(1):30. PubMed ID: 28416023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified Juvenile Spondyloarthritis Disease Activity Index in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry.
    Srinivasalu H; Treemarcki EB; Rumsey DG; Weiss PF; Colbert RA;
    J Rheumatol; 2023 Apr; 50(4):532-537. PubMed ID: 36319008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Race, Income, and Disease Outcomes in Juvenile Dermatomyositis.
    Phillippi K; Hoeltzel M; Byun Robinson A; Kim S;
    J Pediatr; 2017 May; 184():38-44.e1. PubMed ID: 28410093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and prognostic factor in juvenile dermatomyositis: data of the Spanish registry.
    Carriquí-Arenas S; Mosquera JM; Quesada-Masachs E; López M; Clemente D; Boteanu A; Udaondo C; de Inocencio J; Nieto JC; Riancho L; Núñez E; Sánchez-Manubens J; Lirola MJ; Roldán R; Camacho M; Martínez M; Medrano M; Alcañiz P; Antón J; Iglesias E
    Pediatr Rheumatol Online J; 2024 Jul; 22(1):66. PubMed ID: 39039532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity.
    Pachman LM; Morgan G; Klein-Gitelman MS; Ahsan N; Khojah A
    Pediatr Rheumatol Online J; 2023 Oct; 21(1):118. PubMed ID: 37828536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of eotaxin and MCP-1 in juvenile dermatomyositis median 16.8 years after disease onset; associations with disease activity, duration and organ damage.
    Sanner H; Schwartz T; Flatø B; Vistnes M; Christensen G; Sjaastad I
    PLoS One; 2014; 9(3):e92171. PubMed ID: 24647150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Childhood Arthritis and Rheumatology Research Alliance Biologic DMARD Consensus Treatment Plans for Refractory Moderately Severe Juvenile Dermatomyositis.
    Tarvin SE; Sherman MA; Kim H; Balmuri N; Brown AG; Chow A; Gewanter HL; de Guzman MM; Huber AM; Kim S; Klein-Gitelman MS; Perron MM; Robinson AB; Sabbagh SE; Savani S; Shenoi S; Spitznagle J; Stingl C; Syverson G; Tory H; Spencer C;
    Arthritis Care Res (Hoboken); 2024 Jun; ():. PubMed ID: 38937134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysis.
    Seshadri R; Feldman BM; Ilowite N; Cawkwell G; Pachman LM
    Arthritis Rheum; 2008 Jul; 59(7):989-95. PubMed ID: 18576304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research.
    McCann LJ; Pilkington CA; Huber AM; Ravelli A; Appelbe D; Kirkham JJ; Williamson PR; Aggarwal A; Christopher-Stine L; Constantin T; Feldman BM; Lundberg I; Maillard S; Mathiesen P; Murphy R; Pachman LM; Reed AM; Rider LG; van Royen-Kerkof A; Russo R; Spinty S; Wedderburn LR; Beresford MW
    Ann Rheum Dis; 2018 Feb; 77(2):241-250. PubMed ID: 29084729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease activity trajectories in juvenile dermatomyositis from childhood to adulthood.
    Nozawa T; Pullenayegum EM; Bell-Peter A; Marcuz JA; Whitney K; Vinik O; Shupak R; Dover S; Feldman BM
    Rheumatology (Oxford); 2024 Jan; ():. PubMed ID: 38216715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B Cell Lymphocytosis in Juvenile Dermatomyositis.
    Costin C; Khojah A; Ochfeld E; Morgan G; Subramanian S; Klein-Gitelman M; Tan XD; Pachman LM
    Diagnostics (Basel); 2023 Aug; 13(16):. PubMed ID: 37627885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroid discontinuation, complete clinical response and remission in juvenile dermatomyositis.
    Kishi T; Warren-Hicks W; Bayat N; Targoff IN; Huber AM; Ward MM; Rider LG;
    Rheumatology (Oxford); 2021 May; 60(5):2134-2145. PubMed ID: 33067611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Dysphagia in Myositis: A Systematic Review and Meta-Analysis.
    Labeit B; Pawlitzki M; Ruck T; Muhle P; Claus I; Suntrup-Krueger S; Warnecke T; Meuth SG; Wiendl H; Dziewas R
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32650400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Path to Prediction of Outcomes in Juvenile Idiopathic Inflammatory Myopathy.
    Reed AM; Crowson CS; Dvergsten JA
    Front Immunol; 2019; 10():638. PubMed ID: 31001260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of changes in disease activity among children with juvenile dermatomyositis enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry.
    Challa D; Crowson CS; Niewold TB; Reed AM;
    Clin Rheumatol; 2018 Apr; 37(4):1011-1015. PubMed ID: 29170979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline characteristics of children with juvenile dermatomyositis enrolled in the first year of the new Childhood Arthritis and Rheumatology Research Alliance registry.
    Neely J; Ardalan K; Huber A; Kim S;
    Pediatr Rheumatol Online J; 2022 Jul; 20(1):50. PubMed ID: 35854378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient and physician discordance of global disease assessment in juvenile dermatomyositis: findings from the Childhood Arthritis & Rheumatology Research Alliance Legacy Registry.
    Tory H; Zurakowski D; Kim S;
    Pediatr Rheumatol Online J; 2020 Jan; 18(1):5. PubMed ID: 31941511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Short-Term Ultraviolet Radiation Exposure and Disease Severity in Juvenile Dermatomyositis: Results From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.
    Neely J; Long CS; Sturrock H; Kim S;
    Arthritis Care Res (Hoboken); 2019 Dec; 71(12):1600-1605. PubMed ID: 30714338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CARRA: The Childhood Arthritis and Rheumatology Research Alliance.
    Fuhlbrigge RC; Schanberg LE; Kimura Y
    Rheum Dis Clin North Am; 2021 Nov; 47(4):531-543. PubMed ID: 34635290
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.